MA
NPSP

MUFG Americas’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

MUFG Americas’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-28,800
Closed -$435K – 1659
2013
Q2 		$435K Buy
+28,800
New +$399K 0.01% 707

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MUFG Americas's NPSP Position: Q3 2013 in Review

MUFG Americas sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2013, closing a stake of 28,800 shares — an estimated $435K sold.

MUFG Americas first reported a position in NPSP in Q2 2013 and held it in 1 quarter. The position peaked at $435K in Q2 2013. 182 funds tracked by Wall St. Rank hold NPSP as of Q3 2013.

  • MUFG Americas reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • MUFG Americas sold 28,800 NPS PHARMACEUTICALS INC shares in Q3 2013, an estimated $435K.
  • MUFG Americas first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • MUFG Americas's NPS PHARMACEUTICALS INC position peaked at $435K in Q2 2013.
  • 182 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2013.

Based on MUFG Americas's 13F filing for Q3 2013, filed 8 Nov 2013.